Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Vaso-Occlusive Crises, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell diseaseRecruitingPhase 22026-08-05NCT07224360

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
CSL Behring25

16 results · Page 1 of 1

Swipe the table sideways for more columns.